Evidence-Based Care in Atopic Dermatitis: Mapping IL-13 to the Clinical Manifestations of Moderate to Severe Disease

Update: 2025-06-24

Description

In this episode, Andrew F. Alexis, MD, MPH, and Daniel C. Butler, MD, discuss the immunopathogenesis and role of IL-13 in atopic dermatitis (AD), including:

Contributors to epidermal barrier dysfunction (eg, environmental triggers)
IL-13 as a key cytokine in AD pathogenesis
Targeted AD therapies that inhibit IL-13
A detailed patient case to highlight take-home points

Presenter

Andrew F. Alexis, MD, MPH
Professor of Clinical Dermatology
Weill Cornell Medical College
New York, New York

Daniel C. Butler, MD
Assistant Dean Student Affairs
University of Arizona College of Medicine – Tucson
Tucson, Arizona

Program page:
https://bit.ly/4kTP04D

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Comments

In Channel

Patient Perspectives on New Developments in PBC: Individualizing Patient Care Podcast

2025-10-2012:48

Keeping Up With New Developments in PBC

2025-10-1748:04

Conversations in Chronic Cough: A Pulmonologist’s Perspective

2025-09-0916:43

Conversations in Chronic Cough: An Otolaryngologist’s Perspective

2025-07-1118:07

Quality Improvement in Obesity Care: How to Integrate Comprehensive Diabetes Management

2025-07-1019:17

Key PBC Studies From EASL and DDW 2025

2025-07-0718:54

Evidence-Based Care in Atopic Dermatitis: Practical Considerations for IL-13 Inhibitors for Moderate to Severe Disease

2025-06-2509:53

Evidence-Based Care in Atopic Dermatitis: IL-13 Inhibitors to Treat Moderate to Severe Disease

2025-06-2515:48

Quality Improvement in Obesity Care: How to Manage Prior Authorizations for Antiobesity Medications

2025-06-2427:06

Evidence-Based Care in Atopic Dermatitis: Mapping IL-13 to the Clinical Manifestations of Moderate to Severe Disease

2025-06-2411:40

Innovations in NCFBE: Latest Advances and Personalization of Treatment

2025-06-2015:39

Heart Failure and MRAs: Diving Deep Into the Pivotal FINEARTS-HF Trial

2025-06-1822:14

Innovations in NCFBE: Understanding the Patient Burden and Best Practices in Diagnostics

2025-06-1823:32

Quality Improvement in Obesity Care: How to Develop Patient-Centered and Tailored Treatment Plans

2025-06-1327:07

Conversations in Chronic Cough: An Allergist’s Perspective

2025-05-2816:36

Expert Guidance in Alpha-1 Antitrypsin Deficiency: Why Early Detection and Multidisciplinary Management Are Key

2025-05-0930:18

Quality Improvement in Obesity Care: How to Implement Virtual Support Groups

2025-05-0727:27

Quality Improvement in Obesity Care: How to Implement Documentation Shortcuts

2025-04-1124:05

Partnering With Patients for PBC Care: Actionable Strategies for HCPs

2025-04-0113:45

Debating the Role of ALP Normalization in PBC: Curbside Consults Podcast

2025-03-2421:00

00:00

Evidence-Based Care in Atopic Dermatitis: Mapping IL-13 to the Clinical Manifestations of Moderate to Severe Disease

Andrew F. Alexis MD MPH, Daniel C. Butler MD

#box-pro-ellipsis-176172508295143{-webkit-line-clamp:2;}Evidence-Based Care in Atopic Dermatitis: Mapping IL-13 to the Clinical Manifestations of Moderate to Severe Disease

Evidence-Based Care in Atopic Dermatitis: Mapping IL-13 to the Clinical Manifestations of Moderate to Severe Disease

Andrew F. Alexis MD MPH, Daniel C. Butler MD

Evidence-Based Care in Atopic Dermatitis: Mapping IL-13 to the Clinical Manifestations of Moderate to Severe Disease